Adults 20 to 80, any sex, with Myelopathy Cervical or Kyphosis Post Surgical. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
C2-C7 LordosisPrimary· at 1, 2, 3 year (linear mixed-effect model analysis was used for repeated measurements)
Measuring C2-C7 lordosis angle by using standard lateral cervical x-ray series protocol with the patients standing in a neutral position and instructed to look straight ahead with knees locked.
Group
Value
95% CI
C3 Laminectomy With C4-6 Laminoplasty
11.0
± 0.8
C3-6 Laminoplasty
10.9
± 0.8
the Neck Disability Index (NDI)Primary· at 1, 2, 3 year (linear mixed-effect model analysis was used for repeated measurements)
scores from 0 to 50 with 50 being the worst performance status related to neck pain.
Group
Value
95% CI
C3 Laminectomy With C4-6 Laminoplasty
12.8
± 1.0
C3-6 Laminoplasty
8.6
± 1.0
C2-C3 LordosisSecondary· at 1, 2, 3 year (linear mixed-effect model analysis was used for repeated measurements)
Measuring C2-C3 lordosis by using standard lateral cervical x-ray series protocol with the patients standing in a neutral position and instructed to look straight ahead with knees locked.
Group
Value
95% CI
C3 Laminectomy With C4-6 Laminoplasty
7.1
± 0.5
C3-6 Laminoplasty
3.2
± 0.5
C4-C7 LordosisSecondary· at 1, 2, 3 year (linear mixed-effect model analysis was used for repeated measurements)
Measuring C4-C7 lordosis by using standard lateral cervical x-ray series protocol with the patients standing in a neutral position and instructed to look straight ahead with knees locked.
Group
Value
95% CI
C3 Laminectomy With C4-6 Laminoplasty
3.9
± 0.8
C3-6 Laminoplasty
7.7
± 0.7
Cervical Sagittal Vertical Axis (cSVA)Secondary· at 1, 2, 3 year (linear mixed-effect model analysis was used for repeated measurements)
Measuring cervical sagittal vertical axis by using standard lateral cervical x-ray series protocol with the patients standing in a neutral position and instructed to look straight ahead with knees locked.
Group
Value
95% CI
C3 Laminectomy With C4-6 Laminoplasty
31.6
± 1.4
C3-6 Laminoplasty
25.5
± 1.3
T1 SlopeSecondary· at 1, 2, 3 year (linear mixed-effect model analysis was used for repeated measurements)
Measuring T1 slope by using standard lateral cervical x-ray series protocol with the patients standing in a neutral position and instructed to look straight ahead with knees locked.
Group
Value
95% CI
C3 Laminectomy With C4-6 Laminoplasty
25.8
± 0.6
C3-6 Laminoplasty
25.3
± 0.6
T1 Slope Minus Cervical LordosisSecondary· at 1, 2, 3 year (linear mixed-effect model analysis was used for repeated measurements)
Measuring T1 slope minus cervical lordosis by using standard lateral cervical x-ray series protocol with the patients standing in a neutral position and instructed to look straight ahead with knees locked.
Group
Value
95% CI
C3 Laminectomy With C4-6 Laminoplasty
15.0
± 1.0
C3-6 Laminoplasty
14.9
± 0.9
C2-C3 Interlaminar Spontaneous FusionSecondary· at 2 year
Measuring the incidence of postoperative C2-C3 interlaminar spontaneous fusion by using standard lateral cervical x-ray series.
Group
Value
95% CI
C3 Laminectomy With C4-6 Laminoplasty
5
C3-6 Laminoplasty
26
EuroQol Five-dimensional Questionnaire (EQ-5D) ScoresSecondary· at 1, 2, 3 year (linear mixed-effect model analysis was used for repeated measurements)
Responses on a questionnaire with five dimensions, each comprised of five levels. Scores are revised into an index with a range from -0.59-1, with 1.00 indicating full health. The 243 possible health states on the EQ-5D are evaluated against a normal population using the time trade off method (TTO).
Group
Value
95% CI
C3 Laminectomy With C4-6 Laminoplasty
0.661
± 0.025
C3-6 Laminoplasty
0.743
± 0.024
Posterior Neck With Numering Rating Scale (NRS-N)Secondary· at 1, 2, 3 year (linear mixed-effect model analysis was used for repeated measurements)
Measuring pain intensity of the posterior neck with numeric rating scale (NRS), rated 1 to 10 with 10 being the most severe pain level.
Group
Value
95% CI
C3 Laminectomy With C4-6 Laminoplasty
2.8
± 0.3
C3-6 Laminoplasty
2.0
± 0.3
Upper Limb Pain With Numering Rating Scale (NRS-L)Secondary· at 1, 2, 3 year (linear mixed-effect model analysis was used for repeated measurements)
Measuring pain intensity of the upper limb with numeric rating scale (NRS), rated 1 to 10 with 10 being the most severe pain level.
Measuring estimated intraoperative blood loss by using intraoperative records of anesthesiologists.
Group
Value
95% CI
C3 Laminectomy With C4-6 Laminoplasty
169
± 145
C3-6 Laminoplasty
182
± 159
Sponsor's own description
Investigators performed a prospective randomized controlled trial for comparing postoperative clinical and radiological outcomes between C3 laminectomy with laminoplasty and C3-6 laminoplasty.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
NCT04623593 — Cervical Arthroplasty Cost Effectiveness Study (CACES)
· NA
· recruiting
NCT05696470 — Fusion Rates of 3D Printed Porous Titanium Cages in Three and Four Level ACDFs
· active not recruiting
NCT03320759 — Enhancing Recovery in Non-Traumatic Spinal Cord Injury
· NA
· recruiting
Other Seoul National University Hospital trials
Trials by the same sponsor.
NCT07262944 — EOI Block in Otoplasty With Rib Cartilage Graft
· NA
· recruiting
NCT07464210 — Nemtabrutinib, Bortezomib, and Rituximab for WM
· Phase 2
· not yet recruiting
NCT07550803 — Effect of Intraoperative Dexamethasone on Early Postoperative Sleep Quality in Patients Undergoing Nasal Surgery
· NA
· not yet recruiting
NCT07522138 — Home-based Self-exercise in Patients With Parkinson's Disease: A Feasibility Study
· NA
· not yet recruiting
NCT07476651 — Scout Dose of Resin Microspheres
· NA
· recruiting
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Seoul National University Hospital
Last refreshed: 21 June 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05006495.